These results indicate that TPD52 may play a role in lipid storage regulation induced by BFA treatment not only in TPD52-expressing 3T3 cells, but also when endogenously expressed in breast cancer cells that contain prominent LDs. Here, TPD52 is linked to breast carcinoma.